Attached files
| file | filename |
|---|---|
| EX-10.1 - ADDENDUM NO. 1 TO THE SERVICES AGREEMENT BETWEEN HCI VIOCARE CLINICS UK LIMITED AND HELEEN FRANCOISE KIST, DATED OCTOBER 15, 2015 - Rafina Innovations Inc. | ex101.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Date of Report (Date of earliest event reported): October 15, 2015
|
|
HCi Viocare
|
|
Exact name of registrant as specified in its charter
|
|
Nevada
|
000-53089
|
30-0428006
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
Kintyre House, 209 Govan Road, Glasgow, Scotland
|
G51 1 HJ
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
+44 141 3700321
|
|
Registrant’s telephone number, including area code
|
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
SECTION 1. REGISTRANT’S BUSINESS AND OPERATIONS
ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
As used in this Current Report on Form 8-K, unless otherwise stated, all references to the “Company”, “we,” “our” and “us” refer to HCi Viocare.
Extension and increase of remuneration to service agreement
On October 15, 2015, the Company’s subsidiary, HCi Viocare Clinics UK Limited, approved a one-year extension and an increase to annual remuneration with regard to the service agreement (the "Agreement") originally entered into with Mrs. Heleen Francoise Kist, Chief Operating Officer, on November 7, 2014 and filed on Form 8-K with the Securities and Exchange Commission as of November 12, 2014.
The revision to the Agreement ("Addendum No. 1.") has a term of one year, being effective as of October 1, 2015, and ending on September 30, 2016, renewable for such further term as may be mutually agreed between the parties. Compensation shall be forty-five thousand GBP (£45,000) per year payable monthly in arrears on the last Friday of every month by credit transfer.
The Board of Directors of the Company’s subsidiary approved Addendum No. 1.
A copy of Addendum No. 1 is filed as Exhibit 10.1 to this Current Report on Form 8-K.
SECTION 5. CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Appointment of Certain Officers Compensatory Arrangements of Certain Officers
On October 15, 2015 the Board of Directors of the Company's subsidiary approved Addendum No. 1 to a certain services agreement between the Company's Chief Operating Officer, Heleen Francoise Kist and subsidiary, HCi Viocare Clinics UK Limited.
The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.02.
SECTION 9. FINANCIAL STATEMENTS AND EXHIBITS
9.01 Financial Statements and Exhibits
(d) Exhibits.
The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K:
|
Exhibit No.
|
Description
|
|
|
10.1
|
Addendum No. 1 to the services agreement between HCi Viocare Clinics UK Limited and Heleen Francoise Kist, dated October 15, 2015
|
Filed herewith
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
HCi Viocare
|
||
|
Dated: October 16, 2015
|
By:
|
/s/ Sotirios Leontaritis
|
|
Name:
|
Sotirios Leontaritis
|
|
|
`
|
Title:
|
President, Treasurer, CEO, and Director
|
3